rpcardioRational Pharmacotherapy in CardiologyРациональная Фармакотерапия в Кардиологии1819-64462225-3653«SILICEA-POLIGRAF» LLC10.20996/1819-6446-2008-4-1-121-125rpcardio-1081Research ArticleEVIDANCE BASED MEDICINEДОКАЗАТЕЛЬНАЯ МЕДИЦИНАRUN-DOWN AND COMMENTS ON COMPLETED MULTICENTRAL CONTROLLED STUDIESКРАТКАЯ ИНФОРМАЦИЯ И КОММЕНТАРИИ ПО ЗАВЕРШИВШИМСЯ МНОГОЦЕНТРОВЫМ КОНТРОЛИРУЕМЫМ ИССЛЕДОВАНИЯМГиляревскийС. Р.GilyarevskiyS. R.20082801201641121125Copyright © Gilyarevskiy S.R., 20162016Гиляревский С.Р.Gilyarevskiy S.R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.rpcardio.online/jour/article/view/1081
.
Конец 2007 г. не был отмечен какими-либо сенсационными событиями в доказательной кардиологии, однако ряд публикаций, тем не менее, представляет собой несомненный интерес.
ReferencesRouleau J.L., Warnica W.J., Baillot R., et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008;117:24-31.Rouleau J.L., Warnica W.J., Baillot R., et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008;117:24-31.Flather M.D., Yusuf S., Kober L., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systemic view of data from individual patients. Lancet. 2000;355:1575-81.Flather M.D., Yusuf S., Kober L., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systemic view of data from individual patients. Lancet. 2000;355:1575-81.Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53.Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53.Fox K.M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multi-centre trial (the EUROPA study). Lancet 2003;362:782-8.Fox K.M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multi-centre trial (the EUROPA study). Lancet 2003;362:782-8.Braunwald E., Domanski M.J., Fowler S.E., et al.; PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004;351:2058-68.Braunwald E., Domanski M.J., Fowler S.E., et al.; PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004;351:2058-68.Cox J.L., Chiasson D.A., Gotlieb A.I. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991;34:45-68.Cox J.L., Chiasson D.A., Gotlieb A.I. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991;34:45-68.Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and treatment. Circulation 1998;97:16-31.Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and treatment. Circulation 1998;97:16-31.Bourassa M.G. Fate of venous grafts: the past, the present and the future. J Am Coll Cardiol 1991;17:1081-3.Bourassa M.G. Fate of venous grafts: the past, the present and the future. J Am Coll Cardiol 1991;17:1081-3.Sasaki Y., Suehiro S., Becker A.E., et al. Role of endothelial denudation and smooth muscle cell differentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications. Heart 2000;83:69-75.Sasaki Y., Suehiro S., Becker A.E., et al. Role of endothelial denudation and smooth muscle cell differentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications. Heart 2000;83:69-75.Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation. 1996;94:258-65.Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation. 1996;94:258-65.Oosterga M., Voors A.A., Pinto Y.M., et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUO VADIS study). Am J Cardiol. 2001;87:541-6.Oosterga M., Voors A.A., Pinto Y.M., et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUO VADIS study). Am J Cardiol. 2001;87:541-6.Okrainec K., Platt R., Pilote L., Eisenberg M.J. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol. 2005;45:177-84.Okrainec K., Platt R., Pilote L., Eisenberg M.J. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol. 2005;45:177-84.Gibbons R.J., Abrams J., Chatterjee K., et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines, Committee on the Management of Patients With Chronic Stable Angina. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report from the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003;107:149-58.Gibbons R.J., Abrams J., Chatterjee K., et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines, Committee on the Management of Patients With Chronic Stable Angina. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report from the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003;107:149-58.Bravata D.M., Gienger A.L., McDonald K.M., et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147:703-16.Bravata D.M., Gienger A.L., McDonald K.M., et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147:703-16.Hong S.J., Lim D.S., Seo H.S., et al. Percutaneous coronary intervention with drugeluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis. Catheter Cardiovasc Interv 2005;64:75-81.Hong S.J., Lim D.S., Seo H.S., et al. Percutaneous coronary intervention with drugeluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis. Catheter Cardiovasc Interv 2005;64:75-81.BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-66.BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-66.King S.B. 3rd, Kosinski A.S., Guyton R.A., et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 2000;35:1116-21.King S.B. 3rd, Kosinski A.S., Guyton R.A., et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 2000;35:1116-21.Kaehler J., Koester R., Billmann W., et al. 13-year follow-up of the German angioplasty bypass surgery investigation. Eur Heart J 2005;26:2148-53.Kaehler J., Koester R., Billmann W., et al. 13-year follow-up of the German angioplasty bypass surgery investigation. Eur Heart J 2005;26:2148-53.Henderson R.A., Pocock S.J., Sharp S.J., et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet 1998;352:1419-25.Henderson R.A., Pocock S.J., Sharp S.J., et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet 1998;352:1419-25.Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761-9.Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761-9.Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996;335:217-25.Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996;335:217-25.Berger P.B., Velianou J.L., Aslanidou Vlachos H., et al. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2001;38:1440-9.Berger P.B., Velianou J.L., Aslanidou Vlachos H., et al. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2001;38:1440-9.Rodriguez A.E., Baldi J., Fernandez Pereira C., et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005;46:582-8.Rodriguez A.E., Baldi J., Fernandez Pereira C., et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005;46:582-8.Jacobs A.K., Kelsey S.F., Brooks M.M., et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation 1998;98:1279- 85.Jacobs A.K., Kelsey S.F., Brooks M.M., et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation 1998;98:1279- 85.Flachskampf F.A., Gallasch J., Gefeller O., et al. Randomized trial of acupuncture to lower blood pressure. Circulation 2007;115:3121-9Flachskampf F.A., Gallasch J., Gefeller O., et al. Randomized trial of acupuncture to lower blood pressure. Circulation 2007;115:3121-9Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-9.Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-9.
The authors declare that there are no conflicts of interest present.